153 related articles for article (PubMed ID: 22187350)
1. Rifampicin-miconazole-impregnated catheters save cost in jugular venous sites with tracheostomy.
Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1833-6. PubMed ID: 22187350
[TBL] [Abstract][Full Text] [Related]
2. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
[TBL] [Abstract][Full Text] [Related]
3. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
Lorente L; Lecuona M; Jiménez A; Raja L; Cabrera J; Gonzalez O; Diosdado S; Marca L; Mora ML
Am J Infect Control; 2016 Jan; 44(1):50-3. PubMed ID: 26412482
[TBL] [Abstract][Full Text] [Related]
4. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs.
Lorente L; Lecuona M; Jiménez A; Santacreu R; Raja L; Gonzalez O; Mora ML
Am J Infect Control; 2014 Mar; 42(3):321-4. PubMed ID: 24581021
[TBL] [Abstract][Full Text] [Related]
5. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
Clin Infect Dis; 2008 Nov; 47(9):1171-5. PubMed ID: 18808356
[TBL] [Abstract][Full Text] [Related]
6. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML
Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
Gilbert R; Brown M; Faria R; Fraser C; Donohue C; Rainford N; Grosso A; Sinha AK; Dorling J; Gray J; Muller-Pebody B; Harron K; Moitt T; McGuire W; Bojke L; Gamble C; Oddie SJ
Health Technol Assess; 2020 Nov; 24(57):1-190. PubMed ID: 33174528
[TBL] [Abstract][Full Text] [Related]
8. Lower associated costs using rifampicin-miconazole‒impregnated catheters compared with standard catheters.
Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
Am J Infect Control; 2011 Dec; 39(10):895-7. PubMed ID: 21741122
[TBL] [Abstract][Full Text] [Related]
9. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
Chong HY; Lai NM; Apisarnthanarak A; Chaiyakunapruk N
Clin Infect Dis; 2017 May; 64(suppl_2):S131-S140. PubMed ID: 28475779
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial-impregnated central venous catheters for prevention of neonatal bloodstream infection (PREVAIL): an open-label, parallel-group, pragmatic, randomised controlled trial.
Gilbert R; Brown M; Rainford N; Donohue C; Fraser C; Sinha A; Dorling J; Gray J; McGuire W; Gamble C; Oddie SJ;
Lancet Child Adolesc Health; 2019 Jun; 3(6):381-390. PubMed ID: 31040096
[TBL] [Abstract][Full Text] [Related]
11. Five-Lumen Antibiotic-Impregnated Femoral Central Venous Catheters in Severely Burned Patients: An Investigation of Device Utility and Catheter-Related Bloodstream Infection Rates.
Friedman BC; Mian MA; Mullins RF; Hassan Z; Shaver JR; Johnston KK
J Burn Care Res; 2015; 36(4):493-9. PubMed ID: 25407386
[TBL] [Abstract][Full Text] [Related]
12. Influence of tracheostomy on the incidence of catheter-related bloodstream infection in the catheterization of jugular vein by posterior access.
Lorente L; Jiménez A; Roca I; Martín MM; Mora ML
Eur J Clin Microbiol Infect Dis; 2011 Sep; 30(9):1049-51. PubMed ID: 21301912
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors of Central Venous Catheter-Related Bloodstream Infection for Continuous Renal Replacement Therapy in Kidney Intensive Care Unit Patients.
Cheng S; Xu S; Guo J; He Q; Li A; Huang L; Liu Z; Li S
Blood Purif; 2019; 48(2):175-182. PubMed ID: 30485840
[TBL] [Abstract][Full Text] [Related]
14. Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive®) vs conventional catheters in intensive care unit patients.
Antonelli M; De Pascale G; Ranieri VM; Pelaia P; Tufano R; Piazza O; Zangrillo A; Ferrario A; De Gaetano A; Guaglianone E; Donelli G
J Hosp Infect; 2012 Oct; 82(2):101-7. PubMed ID: 22938728
[TBL] [Abstract][Full Text] [Related]
15. New choices for central venous catheters: potential financial implications.
Shorr AF; Humphreys CW; Helman DL
Chest; 2003 Jul; 124(1):275-84. PubMed ID: 12853534
[TBL] [Abstract][Full Text] [Related]
16. Lower incidence of catheter-related bloodstream infection in subclavian venous access in the presence of tracheostomy than in femoral venous access: prospective observational study.
Lorente L; Jiménez A; Martín MM; Palmero S; Jiménez JJ; Mora ML
Clin Microbiol Infect; 2011 Jun; 17(6):870-2. PubMed ID: 21682804
[TBL] [Abstract][Full Text] [Related]
17. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.
Hockenhull JC; Dwan K; Boland A; Smith G; Bagust A; Dündar Y; Gamble C; McLeod C; Walley T; Dickson R
Health Technol Assess; 2008 Apr; 12(12):iii-iv, xi-xii, 1-154. PubMed ID: 18405471
[TBL] [Abstract][Full Text] [Related]
18. Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial.
Yücel N; Lefering R; Maegele M; Max M; Rossaint R; Koch A; Schwarz R; Korenkov M; Beuth J; Bach A; Schierholz J; Pulverer G; Neugebauer EA
J Antimicrob Chemother; 2004 Dec; 54(6):1109-15. PubMed ID: 15537696
[TBL] [Abstract][Full Text] [Related]
19. Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry.
Hentrich M; Böll B; Teschner D; Panse J; Schmitt T; Naendrup JH; Schmidt-Hieber M; Neitz J; Fiegle E; Schalk E
Infection; 2023 Aug; 51(4):1153-1159. PubMed ID: 37016194
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
